Core Insights - Gilat Satellite Networks Ltd. has received a multimillion-dollar order from a large global avionics company for its Sidewinder electronically steered antenna terminals, with deliveries expected within the next six months [1][2]. Group 1: Product and Technology - The Sidewinder ESA platform is gaining momentum in the inflight connectivity market, driven by demand for advanced solutions that offer high performance in a lightweight configuration [2][4]. - Sidewinder ESA is designed for various aviation sectors, including commercial, business, VIP, government, and military, supporting high throughput satellite networks for reliable, high-speed connectivity [3][4]. - The technology features electronic beam steering, which enhances satellite acquisition speed, reliability, and reduces maintenance compared to traditional mechanically steered antennas [3]. Group 2: Company Overview - Gilat Satellite Networks is a leading global provider of satellite-based broadband communications, with over 35 years of experience in developing technology solutions for satellite and ground connectivity [4][5]. - The company offers a comprehensive portfolio that includes software-defined platforms, high-performance satellite terminals, and advanced antennas, catering to both commercial and defense markets [5][6]. - Gilat's products support multiple applications, including government and defense, inflight connectivity, cellular backhaul, and critical infrastructure, while adhering to stringent service level requirements [6].

Core Insights - Cardiff Oncology, Inc. announced positive results from the CRDF-004 Phase 2 clinical trial, demonstrating that onvansertib combined with FOLFIRI/bevacizumab (bev) shows dose-dependent improvements in overall response rates and progression-free survival (PFS) in patients with RAS-mutated metastatic colorectal cancer (mCRC) [1][3][4] Group 1: Clinical Trial Results - The trial showed that the 30 mg dose of onvansertib with FOLFIRI/bev is selected for further registrational trials based on its efficacy [2][3] - In the intent-to-treat analysis, onvansertib with FOLFIRI/bev outperformed both standard of care (SoC) regimens, with a confirmed objective response rate (ORR) of 44.4% for the 30 mg dose [1][3] - Median PFS for the 30 mg onvansertib group was not reached, indicating a potential benefit over SoC [3][4] Group 2: Safety and Tolerability - Onvansertib was reported to be safe and well-tolerated, with no significant additive toxicity observed in the trial [1][3] - Grade 3 or higher adverse events were infrequent, with neutropenia being the most common treatment-emergent adverse event [5] Group 3: Future Plans - Cardiff Oncology plans to initiate a registrational program later this year, pending finalization of trial design in consultation with the FDA [2][3] - The company expects to provide final data and registrational plans in the first half of 2026 [1][3] Group 4: Industry Context - There is a significant unmet need for improved first-line treatment options for patients with RAS-mutated mCRC, as current treatments have not significantly advanced in over two decades [5] - Onvansertib's novel mechanism of action and promising preliminary results support the need for further investigation in a large Phase 3 trial [5]

New Touch controllers bring reliable touch sensing to both very small and very large display formats in modern automotive applicationsCHANDLER, Ariz., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Microchip Technology (Nasdaq: MCHP) has again expanded its maXTouch® M1 family of touchscreen controllers to bring reliable and secure touch detection to an even greater range of automotive displays, now covering free-form widescreen format displays up to 42 inches down to small compact screens in the 2 to 5 inch range. The A ...

DUBAI, United Arab Emirates, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), the leading provider of technology-enabled mass mobility solutions, today announced the launch of its operations in Kuwait, marking a key milestone in the Company’s regional expansion strategy. The launch is anchored by a $2.2 million multi-year contract, reinforcing Swvl’s growing presence across high-value Gulf Cooperation Council (GCC) markets. The Kuwait rollout will see Swvl deplo ...

FORT WORTH, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (NASDAQ: AAL) today reported its fourth-quarter and full-year 2025 financial results, including: Record fourth-quarter revenue of $14.0 billion and record full-year revenue of $54.6 billionThe government shutdown negatively impacted revenue in the fourth quarter by approximately $325 million Fourth-quarter and full-year GAAP net income of $99 million and $111 million, or $0.15 and $0.17 per diluted share, respectivelyExcluding ...

Focus on Optimizing Zgounder Silver Mine and Accelerating the Boumadine Polymetallic ProjectMONTREAL, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to provide its 2026 outlook and present the Corporation’s key operational and strategic priorities that will guide execution in the coming year. All amounts are in U.S. dollars unless otherwise indicated. Highlights 2026 Outlook Total production: 6.2 to 6.8 million silver-equivalent1 ou ...

TORONTO , Jan. 27, 2026 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX: ILLM, OTCQB: ILLMF) (“illumin” or the “Company”) today announced a major upgrade of its advertising platform that delivers clear proof of programmatic performance, connecting advertising activity directly to meaningful business outcomes while budgets are active. The results are meaningful and measurable. illumin’s ecosystem extends audience reach up to 50%, 40% lift in Connected TV performance, and 25% lower retargeting costs, resulting ...

MÜV Deltona is located at 1670 Providence Boulevard, a busy thoroughfare with an average daily traffic count of 8,600 vehicles1The new Deltona dispensary complements four existing MÜV locations in Volusia County, a growing region with over 550,0002 residentsVerano’s active operations span 13 states, comprised of 160 dispensaries and 15 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacity CHICAGO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA ...

TALLAHASSEE, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable to common shareowners of $13.7 million, or $0.80 per diluted share, for the fourth quarter of 2025 compared to $16.0 million, or $0.93 per diluted share, for the third quarter of 2025, and $13.1 million, or $0.77 per diluted share for the fourth quarter of 2024. For 2025, net income attributable to common shareowners totaled $61.6 million, or $3.60 per diluted share, compa ...

Week-Long Series of Activations in the San Francisco Bay Area Culminating in a Star-Studded Fashion Presentation Abercrombie Super Bowl styles for the whole family ranging from $45-$150 online and at an Abercrombie experience within the NFL Shop presented by Visa. Abercrombie Super Bowl styles for the whole family ranging from $45-$150 online and at an Abercrombie experience within the NFL Shop presented by Visa. Abercrombie Super Bowl styles for the whole family ranging from $45-$150 online and at an A ...